New patent for Novartis drug SCEMBLIX

Annual Drug Patent Expirations for SCEMBLIX Scemblix is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are two patents protecting…

Source


Comments are closed.

Biotechblog